Smith & Nephew Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Smith & Nephew şirketinin toplam hissedar öz sermayesi $5.2B ve toplam borcu $3.5B olup, bu da borç-öz sermaye oranını 66.7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $10.5B ve $5.3B dir. Smith & Nephew 'in FAVÖK'ü $735.0M faiz karşılama oranı 6.4 dur. Şirketin $568.0M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

66.7%

Borç/özkaynak oranı

US$3.47b

Borç

Faiz karşılama oranı	6.4x
Nakit	US$568.00m
Eşitlik	US$5.21b
Toplam yükümlülükler	US$5.34b
Toplam varlıklar	US$10.54b

Son finansal sağlık güncellemeleri

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well

Aug 11

Recent updates

Investors Still Waiting For A Pull Back In Smith & Nephew plc (LON:SN.)

Oct 31

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Sep 25

Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are

Aug 08

Smith & Nephew (LON:SN.) Will Be Hoping To Turn Its Returns On Capital Around

Jun 16

Smith & Nephew plc (LON:SN.) Not Flying Under The Radar

Apr 16

Is Smith & Nephew plc (LON:SN.) Trading At A 30% Discount?

Mar 16

Capital Allocation Trends At Smith & Nephew (LON:SN.) Aren't Ideal

Feb 21

Is Smith & Nephew plc (LON:SN.) Trading At A 36% Discount?

Dec 15

Is Smith & Nephew (LON:SN.) Using Too Much Debt?

Nov 30

Smith & Nephew (LON:SN.) Could Be Struggling To Allocate Capital

Oct 29

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price

Sep 11

Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Aug 19

Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital

Jul 17

Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate

Jun 11

Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly

May 09

Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends

Apr 09

Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

Feb 09

We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

Nov 21

Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)

Nov 08

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price

Oct 26

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well

Aug 11

There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital

Jul 28

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 58% Above Its Share Price

Jun 26

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: SN. 'nin kısa vadeli varlıkları ( $4.5B ) kısa vadeli yükümlülüklerini ( $1.8B ) aşıyor.

Uzun Vadeli Yükümlülükler: SN. şirketinin kısa vadeli varlıkları ( $4.5B ) uzun vadeli yükümlülüklerini ( $3.6B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: SN. 'nin net borç/öz sermaye oranı ( 55.8% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: SN. şirketinin borç/öz sermaye oranı son 5 yılda 40.7% seviyesinden 66.7% seviyesine yükseldi.

Borç Kapsamı: SN. 'nin borcu işletme nakit akışı ( 21.1% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: SN. 'in borcuna ilişkin faiz ödemeleri EBIT ( 6.4 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Smith & Nephew Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Smith & Nephew (LON:SN.) Using Too Much Debt?

Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly

We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well

Recent updates

Consensus EPS estimates fall by 15%

Smith & Nephew plc Provides Earnings Guidance for the Full Year 2024 and for 2025

Smith & Nephew plc to Report Fiscal Year 2024 Results on Feb 25, 2025

Investors Still Waiting For A Pull Back In Smith & Nephew plc (LON:SN.)

Smith+Nephew Announces LEGION Hinged Knee System Now Available in the United States with Proprietary OXINIUM (Oxidized Zirconium)

Smith+Nephew Announces Board and Committee Changes

Upcoming dividend of US$0.14 per share

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are

Consensus EPS estimates fall by 16%

First half dividend of US$0.14 announced

First half 2024 earnings: EPS exceeds analyst expectations

Smith & Nephew plc Provides Revenue Guidance for the Second Half and Reaffirms Earnings Guidance for the Year 2024

Smith+Nephew Announces 510(K) Clearance of New Catalysystem Primary Hip System

Cevian Capital II GP Limited acquired 5.02% stake in Smith & Nephew plc (LSE:SN.).

Consensus EPS estimates increase by 11%

Smith & Nephew (LON:SN.) Will Be Hoping To Turn Its Returns On Capital Around

Smith & Nephew plc Announces Final Dividend of the Year Ended 31 December 2023, Payable on May 22, 2024

Smith & Nephew plc to Report First Half, 2024 Results on Aug 01, 2024

Smith & Nephew plc (LON:SN.) Not Flying Under The Radar

Smith+Nephew Introduces the RENASYS EDGE Negative Pressure Wound Therapy System

Smith & Nephew plc Announces Board Changes

Upcoming dividend of US$0.23 per share

Is Smith & Nephew plc (LON:SN.) Trading At A 30% Discount?

New minor risk - Earnings quality

Smith & Nephew plc, Annual General Meeting, May 01, 2024

Consensus EPS estimates fall by 21%

Final dividend of US$0.23 announced

Smith & Nephew plc Recommends Final Dividend for 2023, Payable on May 22, 2024

Full year 2023 earnings: EPS misses analyst expectations

Capital Allocation Trends At Smith & Nephew (LON:SN.) Aren't Ideal

Smith+Nephew Announces Commercial Launch of Its Aetos Shoulder System for Anatomic and Reverse Shoulder Replacement At Aaos 2024 Annual Meeting

Smith & Nephew plc Announces Standout Results for Its Regeneten Bioinductive Implant from A Recently Completed Randomized Controlled Trial

Smith & Nephew plc (LSE:SN.) acquired CartiHeal (2009) Ltd.

Is Smith & Nephew plc (LON:SN.) Trading At A 36% Discount?

Smith+Nephew Announces Board Changes

Smith+Nephew Announces Board Changes

Is Smith & Nephew (LON:SN.) Using Too Much Debt?

Smith & Nephew plc (LSE:SN.) entered into a definitive agreement to acquire CartiHeal (2009) Ltd. for $330 million.

Smith & Nephew plc Provides Earning Guidance for Full Year 2023

Smith & Nephew plc Announces Appointment of John Rogers as CFO

Smith & Nephew (LON:SN.) Could Be Struggling To Allocate Capital

Smith & Nephew plc Announces Interim Dividend for 2023, Payable 1 November 2023

Upcoming dividend of US$0.14 per share at 3.0% yield

Smith & Nephew plc Announces Board and Committee Changes

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price

Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Smith & Nephew plc Increases Revenue Guidance for 2023

First half 2023 earnings released: EPS: US$0.20 (vs US$0.20 in 1H 2022)

Smith & Nephew plc Announces Step Down of Anne-Françoise Nesmes as Chief Financial Officer

Consensus EPS estimates increase by 10%

Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital

Smith+Nephew Announces 510(K) Clearance of its AETOS Shoulder System

Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate

Now 22% undervalued

Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly

Now 20% undervalued

Insider recently bought UK£117k worth of stock

Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends

Upcoming dividend of US$0.23 per share at 2.6% yield

Chief Human Resources Officer recently sold UK£111k worth of stock

Consensus EPS estimates fall by 12%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

Smith & Nephew plc, Annual General Meeting, Apr 26, 2023

Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

High number of new directors

CEO & Director exercised options to buy UK£59k worth of stock.

Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)

Smith & Nephew plc to Report Fiscal Year 2022 Results on Feb 21, 2023